Literature DB >> 23210757

Update: medical treatment of onychomycosis.

Avner Shemer1.   

Abstract

The diagnosis of onychomycosis should be made clinically and mycologically: clinically, by one of seven subtypes of onychomycosis, and mycologically, by evidence of dermatophytes or verified presence of molds and/or yeasts. Dermatophytes are usually considered as pathogens, whereas non-dermatophyte molds and yeasts are saprophytes. Basic anamnesis and close inspection should be performed to eliminate combined diseases (e.g., onychomycosis and trauma). The gold standard treatment for onychomycosis is basically systemic. Combination with topical agents, such as nail lacquer and/or chemical nail avulsion, produces better results than systemic treatment alone. Topical treatment as monotherapy is not efficient, excluding minor cases. Terbinafine is superior to itraconazole for dermatophyte onychomycosis. Evaluation of the outcome of clinical cure, mycological cure and total cure should be based on the well-defined worldwide criteria; otherwise, comparison of results is impossible due to lack of uniformity in different studies. In case of treatment failure, the reasons for each failure should be carefully considered.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23210757     DOI: 10.1111/j.1529-8019.2012.01551.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  9 in total

Review 1.  Variability in Systemic Treatment Efficacy for Onychomycosis: Information That Clinical Studies Do Not Impart to the Office Dermatologist.

Authors:  Avner Shemer; Ralph Daniel; Dimitris Rigopoulos; Renata Farhi; Meir Babaev
Journal:  Skin Appendage Disord       Date:  2017-10-26

2.  [Effect of 0.9-ms 1064-nm Nd:YAG laser combined with itraconazole for treatment of toenail onychomycosis].

Authors:  Ze-Min Zhong; Ye-Mei Yang; Si-Tong Zhou; Yong-Xuan Hu; Zu-Hao Mao; Zhong Wu; Xue Han; Kang-Xing Liu; Shi-Yun Hunag; Yan-Qing Hu; Yan Lu; Xian-Yi Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-03-20

3.  Aplastic anemia associated with oral terbinafine: a case report and review of the literature.

Authors:  Bülent Kantarcıoğlu; Hüseyin Kemal Türköz; Güven Yılmaz; Funda Pepedil Tanrıkulu; Işık Kaygusuz Atagündüz; Cafer Adıgüzel; Tülin Fıratlı Tuğlular
Journal:  Turk J Haematol       Date:  2014-12-05       Impact factor: 1.831

4.  Efficacy of Two-Stage Treatment of Onychomycosis Using a Long-Pulsed Nd:YAG 1064-nm Laser.

Authors:  Shan Zhong; Guan-Ting Lin; Jun-Ying Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2019-06-16       Impact factor: 2.629

5.  Different Numbers of Long-Pulse 1064-nm Nd-YAG Laser Treatments for Onychomycosis: A Pilot Study.

Authors:  Rui-Na Zhang; Feng-Lin Zhuo; Dong-Kun Wang; Li-Zhi Ma; Jun-Ying Zhao; Lin-Feng Li
Journal:  Biomed Res Int       Date:  2020-01-20       Impact factor: 3.411

Review 6.  Onychomycosis: An Updated Review.

Authors:  Alexander K C Leung; Joseph M Lam; Kin F Leong; Kam L Hon; Benjamin Barankin; Amy A M Leung; Alex H C Wong
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2020

7.  Molecular characterization and antifungal activity against non-dermatophyte molds causing onychomycosis.

Authors:  Keyvan Pakshir; Mandana Kamali; Hasti Nouraei; Kamiar Zomorodian; Marjan Motamedi; Mozhgan Mahmoodi
Journal:  Sci Rep       Date:  2021-10-20       Impact factor: 4.379

8.  Psychosocial perception of adults with onychomycosis: a blinded, controlled comparison of 1,017 adult Hong Kong residents with or without onychomycosis.

Authors:  Henry Hl Chan; Emma T Wong; Chi Keung Yeung
Journal:  Biopsychosoc Med       Date:  2014-07-15

9.  Treatment of onychomycosis using a 1064-nm diode laser with or without topical antifungal therapy: a single-center, retrospective analysis in 56 patients.

Authors:  G C Weber; P Firouzi; A M Baran; E Bölke; H Schrumpf; B A Buhren; B Homey; P A Gerber
Journal:  Eur J Med Res       Date:  2018-10-24       Impact factor: 2.175

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.